Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Klotho Neurosciences Inc
KLTO
Alternate Symbol(s):
KLTOW
Healthcare
Biotechnology
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer’s disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig’s disease. The company was formerly known as Anew Medical, Inc. and changed...
its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:KLTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 16, 2025 8:02am
New Press Release - Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team will attend Longevity Biotech 2025 in Boston, Massachusetts, on October 22–23, 2025. The conference...
read article.
(3)
•••
bioreactor
X
Comment by
bioreactor
on Oct 09, 2025 12:54pm
RE:That was fast!
...or perhaps it pushed someone's hand and one of the big guys made a better offer???
(3)
•••
bioreactor
X
Post by
bioreactor
on Oct 09, 2025 11:11am
That was fast!
I kinda feel like a ping pong ball. Do I understand correctly? The letter was signed about a week before they let it expire?
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 07, 2025 6:21pm
New Press Release - Klotho Neurosciences Announces Expiration of Letter of Intent
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire by the parties.Following careful evaluation, Klotho's Board of Directors determined that the...
read article.
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 30, 2025 8:45pm
The HanAll Biopharma-Turn Biotechnologies Partnership Part 2
Cash Flow Profile: Low immediate inflow ($1M upfront), but milestones provide runway without equity dilution. HanAll's Q2 2024 financials (revenue: 31.6 billion KRW/~$23M) indicate capacity to
...more
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 30, 2025 8:44pm
The HanAll Biopharma-Turn Biotechnologies Partnership Part 1
The HanAll Biopharma-Turn Biotechnologies Partnership The $300 million partnership referenced in Klotho Neurosciences' (KLTO) September 30, 2025, Letter of Intent (LOI) to acquire key assets
...more
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 30, 2025 8:39pm
Likely Pharma Partner???
This is the possible pharma partner that they are talking about. https://www.prnewswire.com/news-releases/hanall-biopharma-signs-licensing-agreement-with-turn-biotechnologies-to-develop-novel
...more
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 30, 2025 8:30pm
Overview of the Deal (KLTO and Turn Bio...)
On September 30, 2025, Klotho Neurosciences, Inc. (NASDAQ: KLTO), a biotech company focused on developing Klotho-based therapies for age-related cognitive and neurodegenerative disorders, signed a non
...more
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 30, 2025 8:15pm
Am I missing something?
What's being done to protect shareholder value?
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 30, 2025 8:14pm
KLTO Signs LOI... Acquire... Assets of Turn Biotechnologies
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership https://www.prnewswire.com/news-releases/klotho
...more
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 28, 2025 5:08pm
What about news from the Conference????
I feel like we're playing a board game. https://ca.investing.com/news/sec-filings/klotho-neurosciences-amends-agreement-with-meteora-funds-caps-shares-at-676-million-93CH-4219438
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 15, 2025 9:45am
Conference Today
I think this is a watershed moment in science and medicine. Klotho Protein is so under the radar. For the sake of all of those suffering from low Klotho levels and their specific type of illness I
...more
(3)
•••
bioreactor
X
Post by
bioreactor
on Sep 10, 2025 1:34pm
Less than a week to Conference
KLTO has a large presence at the Klotho Conference. This should be interesting. A good opportunity for management to advance things on an faster schedule. Should be lots of deals over meals and drinks
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 08, 2025 8:00am
New Press Release - Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative diseases, announces CEO and Chairman Dr. Joseph Sinkule will attend the Inaugural Klotho Conference...
read article.
(3)
•••
bioreactor
X
Post by
bioreactor
on Aug 28, 2025 2:44pm
Meaning of the Klotho Conference
The fact that there is now an industry conference and it is attracting heavy hitters in the field indicates that we are on the cusp of a completely new area of medical therapies with promise for
...more
Prev
1
2
3
4
5
6
7
8
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Podcasts